Motus GI Holdings, Inc.

Equities

MOTS

US62014P5044

Advanced Medical Equipment & Technology

Delayed OTC Markets Other stock markets 11:50:00 2024-05-03 am EDT			5-day change	1st Jan Change
0.0751 ^USD	-0.53%		-7.28%	-94.11%

Apr. 18	Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from S&P TMI Index	CI
Apr. 15	Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from NASDAQ Composite Index	CI

Motus GI Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023

August 14, 2023 at 04:01 pm EDT

Motus GI Holdings, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.113 million compared to USD 0.185 million a year ago. Net loss was USD 3 million compared to USD 5.14 million a year ago. Basic loss per share from continuing operations was USD 6 compared to USD 27.9 a year ago.
For the six months, sales was USD 0.169 million compared to USD 0.205 million a year ago. Net loss was USD 7.38 million compared to USD 9.95 million a year ago. Basic loss per share from continuing operations was USD 18 compared to USD 55.8 a year ago.

Latest news about Motus GI Holdings, Inc.

Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from S&P TMI Index	Apr. 17	CI
Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from NASDAQ Composite Index	Apr. 14	CI
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q4 Revenue $64,000	Mar. 18	MT
Motus GI Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Motus GI Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 18	CI
Transcript : Motus GI Holdings, Inc. - Shareholder/Analyst Call	Mar. 07
Motus GI Holdings, Inc. Publishes Positive Results from A European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with A History of Poor Bowel Preparation	Jan. 30	CI
Top Midday Decliners	Dec. 19	MT
Looming Inflation Data Stifle US Equity Futures Pre-Bell	Dec. 19	MT
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon	Dec. 19	MT
Motus GI Holdings Prices $5 Million Offering of Shares, Warrants	Dec. 19	MT
Top Premarket Decliners	Dec. 19	MT
Top Premarket Gainers	Dec. 11	MT
Top Premarket Gainers	Dec. 05	MT
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q3 Revenue $86,000	Nov. 13	MT
Motus GI Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Motus GI's Pure-Vu EVS Gastro Used in First Procedure	Nov. 10	DJ
Motus GI Holdings, Inc. Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu®? EVS Gastro	Nov. 10	CI
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading	Nov. 09	MT
Top Premarket Gainers	23-10-30	MT
Motus GI Holdings, Inc. Receives Fda Clearance to Commercialize Pure-Vu Evs Gastro and Gen 4 Colon	23-10-24	CI
Motus Gi Submits Special 510(K) to Fda for Pure-Vu Evs Gen 4 Gastro and Colon	23-09-26	CI
Motus GI Holdings, Inc. Announces Executive Changes	23-09-05	CI
Earnings Flash (MOTS) MOTUS GI HOLDINGS Posts Q2 Revenue $113,000	23-08-14	MT
Motus GI Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI

Chart Motus GI Holdings, Inc.

Duration

Period

More charts

Company Profile

Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
MOTUS GI HOLDINGS, INC.	-94.11%	393K
THERMO FISHER SCIENTIFIC	+8.65%	218B
DANAHER CORPORATION	+7.58%	183B
INTUITIVE SURGICAL, INC.	+13.05%	134B
BOSTON SCIENTIFIC CORPORATION	+25.51%	106B
SIEMENS HEALTHINEERS AG	-1.33%	61.12B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	-0.15%	40.3B
GE HEALTHCARE TECHNOLOGIES INC.	+3.29%	35.53B
RESMED, INC.	+26.65%	32.05B

Other Advanced Medical Equipment & Technology